The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk than penny stocks, though they’re not immune to volatility as many lack the scale advantages of their larger peers.
These dynamics can cause headaches for even the most seasoned professionals, which is why we started StockStory - to help you separate the good companies from the bad. That said, here is one stock under $50 with massive upside potential and two that could be down big.
Two Stocks Under $50 to Sell:
Apogee (APOG)
Share Price: $38
Involved in the design of the Apple Store on Fifth Avenue in New York City, Apogee (NASDAQ: APOG) sells architectural products and services such as high-performance glass for commercial buildings.
Why Does APOG Fall Short?
- Sales stagnated over the last five years and signal the need for new growth strategies
- Projected sales for the next 12 months are flat and suggest demand will be subdued
- Capital intensity has ramped up over the last five years as its free cash flow margin decreased by 2.8 percentage points
At $38 per share, Apogee trades at 9x forward P/E. Check out our free in-depth research report to learn more about why APOG doesn’t pass our bar.
Tandem Diabetes (TNDM)
Share Price: $20.55
With technology that automatically adjusts insulin delivery based on continuous glucose monitoring data, Tandem Diabetes Care (NASDAQ: TNDM) develops and manufactures automated insulin delivery systems that help people with diabetes manage their blood glucose levels.
Why Should You Sell TNDM?
- Disappointing pump shipments over the past two years suggest it might have to lower prices to accelerate growth
- Earnings per share fell by 42.6% annually over the last five years while its revenue grew, showing its incremental sales were much less profitable
- Limited cash reserves may force the company to seek unfavorable financing terms that could dilute shareholders
Tandem Diabetes’s stock price of $20.55 implies a valuation ratio of 34.6x forward EV-to-EBITDA. Dive into our free research report to see why there are better opportunities than TNDM.
One Stock Under $50 to Watch:
Trustmark (TRMK)
Share Price: $34.08
Tracing its roots back to 1889 in Mississippi, Trustmark (NASDAQ: TRMK) is a financial services organization providing banking, wealth management, insurance, and mortgage services across five southeastern states.
Why Are We Positive On TRMK?
- Decent 9.2% annual net interest income growth over the last four years beat most of its peers, showing borrowers find value in its loans
- Earnings growth has massively outpaced its peers over the last two years as its EPS has compounded at 9.5% annually
- Balance sheet strength has increased this cycle as its 20.2% annual tangible book value per share growth over the last two years was exceptional
Trustmark is trading at $34.08 per share, or 1x forward P/B. Is now a good time to buy? See for yourself in our full research report, it’s free.
High-Quality Stocks for All Market Conditions
Market indices reached historic highs following Donald Trump’s presidential victory in November 2024, but the outlook for 2025 is clouded by new trade policies that could impact business confidence and growth.
While this has caused many investors to adopt a "fearful" wait-and-see approach, we’re leaning into our best ideas that can grow regardless of the political or macroeconomic climate. Take advantage of Mr. Market by checking out our Top 9 Market-Beating Stocks. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025).
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-small-cap company Exlservice (+354% five-year return). Find your next big winner with StockStory today for free. Find your next big winner with StockStory today. Find your next big winner with StockStory today
